Literature DB >> 6989049

Quantitation of plasma azathioprine and 6-mercaptopurine levels in renal transplant patients.

S N Lin, K Jessup, M Floyd, T P Wang, C T van Buren, R M Caprioli, B D Kahan.   

Abstract

The plasma of renal transplant patients was analyzed by high performance liquid chromatography (HPLC) for the presence of azathioprine and its primary metabolite, 6-mercaptopurine, after either oral or i.v. administration of azathioprine. Azathioprine was demonstrated in plasma at peak concentrations of 0.6 microgram/ml 15 min after i.v. injections of 100 to 200 mg. Within 90 min of injection, the azathioprine level fell to 10 ng/ml. Azathioprine was not detected in plasma at any time after an oral dose of 100 mg, indicating that the plasma concentration is less than 0.5 ng/ml, which is the sensitivity limit of this assay. 6-Mercaptopurine appeared in the plasma after either oral or i.v. azathioprine administration. Furthermore, decreased renal graft function has no effect on the rate of disappearance of azathioprine from plasma. These results demonstrate that high performance liquid chromatography can be used to determine azathioprine and 6-mercaptopurine levels in man, and that alteration in renal function does not influence early stages of azathioprine degradation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6989049     DOI: 10.1097/00007890-198004000-00006

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

Review 1.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 3.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

4.  Thiopurine S-methyltransferase as a target for drug interactions.

Authors:  Hua-Wen Xin; Christine Fischer; Matthias Schwab; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2005-06-11       Impact factor: 2.953

5.  Plasma concentrations and organ distribution of thiopurines after oral application of azathioprine in mice.

Authors:  V Kurowski; H Iven
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  Effect of levamisole and azathioprine on the human mixed lymphocyte reaction (MLR).

Authors:  S A Al-Safi; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

7.  Strength of the human mixed lymphocyte reaction (MLR) and its suppression by azathioprine or 6-mercaptopurine.

Authors:  S A Al-Safi; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

8.  Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate.

Authors:  F Innocenti; R Danesi; A Di Paolo; B Loru; C Favre; M Nardi; G Bocci; D Nardini; P Macchia; M Del Tacca
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

9.  Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine.

Authors:  G L Chan; G R Erdmann; S A Gruber; P Stock; S Chen; N L Ascher; D M Canafax
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 10.  Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?

Authors:  Gabriele Stocco; Marco Pelin; Raffaella Franca; Sara De Iudicibus; Eva Cuzzoni; Diego Favretto; Stefano Martelossi; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.